Gracell Biotechnologies Inc. financial data

Industry
Pharmaceutical Preparations
Location
Building 3, 418 Guilin Road, Xuhui District, Shanghai, China
State of incorporation
Cayman Islands
Fiscal year end
December 31
Latest financial report
20-F - Q4 2022 - Apr 25, 2023

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 338M shares -2.25%
Common Stock, Shares, Outstanding 341M shares +0.68%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 163M USD -28.7%
Other Assets, Current 125K USD +47.1%
Assets, Current 172M USD -33.8%
Property, Plant and Equipment, Net 14.7M USD -8.95%
Operating Lease, Right-of-Use Asset 1.78M USD -46.3%
Other Assets, Noncurrent 1.5M USD -65.9%
Assets 190M USD -33%
Liabilities, Current 26.7M USD -17.5%
Operating Lease, Liability, Noncurrent 351K USD -68.9%
Other Liabilities, Noncurrent 669K USD -42.3%
Liabilities 33.3M USD -21.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 16.3M USD +518%
Retained Earnings (Accumulated Deficit) -265M USD -34.4%
Stockholders' Equity Attributable to Parent 157M USD -34.9%
Liabilities and Equity 190M USD -33%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 341M shares +0.68%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 163M USD -28.7%
Deferred Tax Assets, Valuation Allowance 70.5M USD +71.9%
Deferred Tax Assets, Gross 70.5M USD +58.8%
Operating Lease, Liability 2.07M USD -48.3%
Lessee, Operating Lease, Liability, to be Paid 2.12M USD -48.5%
Property, Plant and Equipment, Gross 36.5M USD +12.8%
Operating Lease, Liability, Current 1.72M USD -40.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 623K USD +103%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.28M USD -39.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 224K USD
Deferred Tax Assets, Operating Loss Carryforwards 64M USD +48.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD